Breast Cancer With Over-expression of erbB2 Study of the Treatment Paradigm in Metastasis to BRAIN (BRAINSTORM).
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2015
At a glance
- Drugs Lapatinib (Primary) ; Trastuzumab
- Indications Breast cancer; Cancer metastases
- Focus Therapeutic Use
- Acronyms BRAINSTORM
- Sponsors GlaxoSmithKline
- 02 Sep 2011 Actual end date Jul 2011 added as reported by ClinicalTrials.gov.
- 02 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2010 New trial record